These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 36273736)
1. Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis. Roesch J; Oertel M; Wegen S; Trommer M; Schleifenbaum J; Hering D; Mäurer M; Knippen S; Dobiasch S; Waltenberger M; von der Grün J; Medenwald D; Süß C; Hoeck M; Käsmann L; Fleischmann DF; Rühle A; Nicolay NH; Fabian A; Löser A; Heß S; Tamaskovics B; Vinsensia M; Hecht M; Radiother Oncol; 2023 Apr; 181():109380. PubMed ID: 36273736 [TBL] [Abstract][Full Text] [Related]
2. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer. Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456 [TBL] [Abstract][Full Text] [Related]
3. Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis. Caudell JJ; Ward MC; Riaz N; Zakem SJ; Awan MJ; Dunlap NE; Isrow D; Hassanzadeh C; Vargo JA; Heron DE; Marcrom S; Boggs DH; Reddy CA; Dault J; Bonner JA; Higgins KA; Beitler JJ; Koyfman SA; Machtay M; Yao M; Trotti AM; Siddiqui F; Lee NY; Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):606-617. PubMed ID: 29413274 [TBL] [Abstract][Full Text] [Related]
4. Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial. Saba NF; Wong SJ; Nasti T; McCook-Veal AA; McDonald MW; Stokes WA; Anderson AM; Ekpenyong A; Rupji M; Abousaud M; Rudra S; Bates JE; Remick JS; Joshi NP; Woody NM; Awan M; Geiger JL; Shreenivas A; Samsa J; Ward MC; Schmitt NC; Patel MR; Higgins KA; Teng Y; Steuer CE; Shin DM; Liu Y; Ahmed R; Koyfman SA JAMA Oncol; 2024 Jul; 10(7):896-904. PubMed ID: 38780927 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and selection criteria in the retreatment of head and neck cancers. May ME; Cash ED; Silverman CL; Redman RA; Perez CA; Wilson LD; Tennant PA; Bumpous JM; Dunlap NE Oral Oncol; 2019 Jan; 88():85-90. PubMed ID: 30616802 [TBL] [Abstract][Full Text] [Related]
6. Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors. Buglione M; Maddalo M; Mazzeo E; Bonomo P; Spiazzi L; Bruni A; Paiar F; Triggiani L; Greto D; Rubino L; Livi L; Bertoni F; Magrini SM Tumori; 2015; 101(5):585-92. PubMed ID: 26108237 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic. Curtis KK; Ross HJ; Garrett AL; Jizba TA; Patel AB; Patel SH; Wong WW; Halyard MY; Ko SJ; Kosiorek HE; Foote RL Radiat Oncol; 2016 Apr; 11():55. PubMed ID: 27061083 [TBL] [Abstract][Full Text] [Related]
8. Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series. Megahed R; Prabhu AV; Mack DP; Gholami S; Samanta S; Patel M; Lewis GD Oral Oncol; 2024 May; 152():106778. PubMed ID: 38555751 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck. Velez MA; Wang PC; Hsu S; Chin R; Beron P; Abemayor E; St John M; Chen AM Am J Otolaryngol; 2018; 39(3):257-260. PubMed ID: 29433815 [TBL] [Abstract][Full Text] [Related]
10. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting? Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810 [TBL] [Abstract][Full Text] [Related]
11. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy. Xu X; Wang Z; Jiang S; Shang Y; Wu Y Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma. Lee A; Woods R; Mahfouz A; Kitpanit S; Cartano O; Mohamed N; Youssef I; Marqueen K; Sine K; Mah D; Neal B; Zakeri K; Kang JJ; Riaz N; Yu Y; McBride SM; Chen LD; Tsai CJ; Gelblum DY; Press RH; Michel LS; Sherman EJ; Pfister D; Dunn LA; Ho AL; Fetten J; Wong RJ; Boyle JO; Singh B; Cracchiolo JR; Ganly I; Cohen MA; Lee NY JAMA Netw Open; 2023 Jan; 6(1):e2250607. PubMed ID: 36689229 [TBL] [Abstract][Full Text] [Related]
13. Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients. Li L; Chen L; Yan L; Guo Y; Li F; Fan M; Lan M; Lai X; Zhou J; Huang Y; Xu P; Lang J; Feng M Radiat Oncol; 2023 Jul; 18(1):109. PubMed ID: 37403098 [TBL] [Abstract][Full Text] [Related]
14. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes. Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656 [TBL] [Abstract][Full Text] [Related]
15. Re-irradiation for recurrent intracranial meningiomas: Analysis of clinical outcomes and prognostic factors. Desideri I; Morelli I; Banini M; Greto D; Visani L; Nozzoli F; Caini S; Della Puppa A; Livi L; Perini Z; Zivelonghi E; Bulgarelli G; Pinzi V; Navarria P; Clerici E; Scorsetti M; Ascolese AM; Osti MF; Anselmo P; Amelio D; Minniti G; Scartoni D Radiother Oncol; 2024 Jun; 195():110271. PubMed ID: 38588920 [TBL] [Abstract][Full Text] [Related]
16. A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer. Vargo JA; Ward MC; Caudell JJ; Riaz N; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Higgins KA; Hassanadeh C; Beitler JJ; Reddy CA; Marcrom S; Boggs DH; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA; Ferris RL; Heron DE Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):595-605. PubMed ID: 28899556 [TBL] [Abstract][Full Text] [Related]
17. A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck. Ward MC; Lee NY; Caudell JJ; Zajichek A; Awan MJ; Koyfman SA; Dunlap NE; Zakem SJ; Hassanzadeh C; Marcrom S; Boggs DH; Isrow D; Vargo JA; Heron DE; Siddiqui F; Bonner JA; Beitler JJ; Yao M; Trotti AM; Riaz N; Oral Oncol; 2019 Mar; 90():80-86. PubMed ID: 30846182 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation. Krstevska V; Tolevska C; Zafirova-Ivanova B; Stojkovski I; Crvenkova S J BUON; 2008; 13(3):369-76. PubMed ID: 18979552 [TBL] [Abstract][Full Text] [Related]
19. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly. Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984 [TBL] [Abstract][Full Text] [Related]
20. Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas. Ohnleiter T; Antoni D; Lefebvre F; Truntzer P; Schultz P; Burgy M; Borel C; Noël G Chin Clin Oncol; 2018 Dec; 7(6):60. PubMed ID: 30180748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]